# OnCo record f-stephen-hodi (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/f-stephen-hodi/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "f-stephen-hodi" ;
  schema:name "F. Stephen Hodi"@en ;
  schema:description "First author of the 2010 ipilimumab trial that proved immunotherapy could extend survival in melanoma."@en ;
  schema:url <https://onco.cc/people/f-stephen-hodi/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.dana-farber.org/find-a-doctor/f-stephen-hodi>, <https://pubmed.ncbi.nlm.nih.gov/?term=Hodi%20FS%5BAuthor%5D> ;
  schema:jobTitle "Director, Melanoma Center and Center for Immuno-Oncology" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/ctla4/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:trials <https://onco.cc/trials/checkmate-067/> ;
  schema:affiliation <https://onco.cc/institutions/dana-farber/> .
